87 related articles for article (PubMed ID: 5865268)
1. [Action of Persantin on the coronary circulation].
Brugger A; Lluch S; Marco V; Esplugues J
Rev Clin Esp; 1965 Sep; 98(6):401-4. PubMed ID: 5865268
[No Abstract] [Full Text] [Related]
2. [Coronary circulation. 2. Coronary resistance, (3) propranolol (Indersal), (4) dipyridamole (Persantin) and vasopressin (Pitressin)].
Saito T
Masui; 1972 May; 21(5):479-86. PubMed ID: 4561562
[No Abstract] [Full Text] [Related]
3. [The comparative studies on the influence of persantin on the coronary circulation in dogs and rabbits].
Filczewski M; Oledzka K; Nowicka J
Acta Physiol Pol; 1969; 20(1):155-63. PubMed ID: 5793303
[No Abstract] [Full Text] [Related]
4. [Action of dipyridamole (Persantin) administered per os on coronary circulation in unanesthetized dogs].
Laubie M
Therapie; 1971; 26(1):197-209. PubMed ID: 5554764
[No Abstract] [Full Text] [Related]
5. [Basic study on application of Persantin for anesthesia].
Saito T; Okazaki K; Hirano T; Matsuzaki T; Wakisaka K
Masui; 1966 Apr; 15(4):322-7. PubMed ID: 6008695
[No Abstract] [Full Text] [Related]
6. Augmentation of coronary collaterals and protection against the consequences of coronary ligation following the administration of dipyridamole.
Schmier J; Kaden F; Schmidt HD
Brux Med; 1970 Sep; 50(9):617-22. PubMed ID: 5510362
[No Abstract] [Full Text] [Related]
7. [Clinical aspects of persantin, segontin and trimanyl in the light of the results of experimental studies on the coronary circulation in dogs].
Janicki K; Wcislo W
Pol Tyg Lek; 1967 May; 22(21):779-81. PubMed ID: 6040998
[No Abstract] [Full Text] [Related]
8. [Pharmacologically-induced development of coronary collaterals in relation to dosage].
Meesmann W; Bachmann GW
Arzneimittelforschung; 1966 Apr; 16(4):501-9. PubMed ID: 6014261
[No Abstract] [Full Text] [Related]
9. [Oxygen pressure and oxygen consumption in coronary venous blood as well as the changes of the arterio-coronary venous O2 content difference and the coronary circulation with high doses of 2,6-(diethanolamino)-4,-8-dipiperidinopyrimido -(5,4-d) pyrimidine (Persantin)].
Doll E; Keul J; Brechtel
Z Kreislaufforsch; 1966 Nov; 55(10):1076-97. PubMed ID: 5998956
[No Abstract] [Full Text] [Related]
10. [Pharmacologic problems of the coronary circulation].
Heidenreich O
Hippokrates; 1966 May; 37(10):374-80. PubMed ID: 4863980
[No Abstract] [Full Text] [Related]
11. [Effect of oxygen and Persantin (dipyridamole) on coronary circulation].
Saito T; Hirano T
Masui; 1972 Feb; 21(2):120-4. PubMed ID: 5063552
[No Abstract] [Full Text] [Related]
12. [Increased tolerance toward coronary occlusion through a pharmacologically increased vascular network].
Schmidt HD; Schmier J
Arzneimittelforschung; 1966 Aug; 16(8):1058-64. PubMed ID: 6014890
[No Abstract] [Full Text] [Related]
13. The pharmacology of coronarotropic drugs using dipyridamole as an example.
Kadatz R
Brux Med; 1970 Sep; 50(9):609-16. PubMed ID: 5510361
[No Abstract] [Full Text] [Related]
14. [On the treatment of coronary circulatory disorders. With special reference to the pyrimidopyrimidine derivative Persantin].
Friedemann M
Schweiz Med Wochenschr; 1966 Dec; 96(49):1656-60. PubMed ID: 5340049
[No Abstract] [Full Text] [Related]
15. Difference in site and time course of coronary dilating effects of trapidil, nitroglycerin and dipyridamole in anesthetized dogs.
Noguchi K; Tomoike H; Ootsubo H; Sakai K; Nakamura M
J Pharmacol Exp Ther; 1981 Dec; 219(3):809-14. PubMed ID: 6795344
[TBL] [Abstract][Full Text] [Related]
16. Persantin.
Med Lett Drugs Ther; 1966 Apr; 8(7):27-8. PubMed ID: 4956154
[No Abstract] [Full Text] [Related]
17. [DEVELOPMENT OF CORONARY COLLATERAL CIRCULATION BY CHRONIC ORAL PERSANTIN THERAPY].
MEESMANN W; BUSCH G; BRAASCH W; BACHMANN GW
Med Welt; 1964 May; 20():1106-11. PubMed ID: 14221265
[No Abstract] [Full Text] [Related]
18. [Effect of persantin on intercoronary collateral circulation and on survival obtained during progressive coronary occlusion in in animals. Preliminary report].
VINEBERG AM; CHARI RS; PIFARRE R; MERCIER C
Union Med Can; 1962 Oct; 91():1068-79. PubMed ID: 14010456
[No Abstract] [Full Text] [Related]
19. [The coronary dilatator effect of various reference drugs].
Duchene-Marullaz P; Cosnier D; Grimald J
Therapie; 1969; 24(4):617-20. PubMed ID: 5821999
[No Abstract] [Full Text] [Related]
20. [Changes in coronary resistance induced by a vasodilator drug].
Costantini S; Vercellio G; Brina A; Mateo Gutierrez AM; Giulini SN; Tardito E
Minerva Cardioangiol; 1970 Nov; 18(11):616-20. PubMed ID: 5500865
[No Abstract] [Full Text] [Related]
[Next] [New Search]
